They are awarded the prize for their internationally leading research, which has created a comprehensive and important scientific basis for the occurrence, causes and treatment of dementia diseases.
Kaj Blenner’s individual pricing motivation reads:
“Professor Kaj Blennow is appointed prize winner for his basic studies of biomarkers for Alzheimer’s and other neurodegenerative diseases, as well as for his epoch-making studies on molecular mechanisms in Alzheimer’s disease.”
The Nordic Medicine Prize is one of Scandinavia’s largest medicine prizes and has been awarded annually to one or more researchers annually as a reward for “particularly prominent scientific efforts” in areas that are of major importance to human health. The prize winners are appointed following a comprehensive nomination procedure, where the 18 medical faculties at the universities of the Nordic region are invited to propose prize winners.
The prize amount of one million SEK is divided by the two prize winners and is distributed on February 1, 2018 in Folksam’s premises at Bohusgatan 14 in Stockholm.